Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study

Artur Bauhofer, Silke Aigner, Stephan Borte

Open source

DOI
10.5414/cp204975
Published
2026-08-01
Container
Int. Journal of Clinical Pharmacology and Therapeutics
Publisher
Dustri-Verlag Dr. Karl Feistle
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5414/cp204975,
  title = {Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study},
  author = {Artur Bauhofer and Silke Aigner and Stephan Borte},
  year = {2026},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  doi = {10.5414/cp204975},
  url = {https://doi.org/10.5414/cp204975}
}

RIS

TY  - JOUR
TI  - Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study
AU  - Artur Bauhofer
AU  - Silke Aigner
AU  - Stephan Borte
PY  - 2026
JO  - Int. Journal of Clinical Pharmacology and Therapeutics
DO  - 10.5414/cp204975
UR  - https://doi.org/10.5414/cp204975
ER  - 

APA

Bauhofer, A., Aigner, S., & Borte, S. (2026). Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204975

Source records